Arrow ErgoPack and AC3 Optimus Product Overview
7
Teleflex Investment Thesis
Global
Leadership
Unique Size
Track Record
of Execution
•
.
•
Leading positions in growing markets (vascular, interventional access, interventional urology)
Established and respected global brands
Global scale to succeed in today's healthcare marketplace
More nimble than larger device companies
Constant currency revenue growth accelerated to 8.1% in FY19; declined 2.4% in 2020
due to COVID-19
490 basis point adjusted gross margin expansion from 2014 – 2020
520 basis point adjusted operating margin expansion from 2014-2020
Adjusted earnings per share CAGR of 10.9% from 2014-2020
Note: See appendicies for reconciliations of non-GAAP financial measures to the most comparable GAAP financial measures.
Teleflex®View entire presentation